Emergent BioSolutions Inc. - COM (EBS)

Historical Holders from Q1 2014 to Q1 2025

Symbol
EBS on NYSE
CUSIP
29089Q105
Type / Class
Equity / COM
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
34.7M
Holdings value
$332M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
156
Number of buys
74
Number of sells
-56
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Emergent BioSolutions Inc. - COM (EBS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 703K $3.42M -$830K $4.86 12
2024 Q4 34.7M $332M +$28.1M $9.56 156
2024 Q3 31.7M $265M +$31M $8.35 138
2024 Q2 30.4M $208M -$26.6M $6.82 138
2024 Q1 35.9M $90.7M -$12M $2.53 116
2023 Q4 39.5M $94.8M -$4.6M $2.40 126
2023 Q3 41.3M $141M -$26.3M $3.40 158
2023 Q2 45.7M $336M +$1.39M $7.35 176
2023 Q1 44.9M $465M -$16.7M $10.36 185
2022 Q4 46.2M $546M +$43.5M $11.81 189
2022 Q3 40.1M $841M -$34.8M $20.99 187
2022 Q2 41.1M $1.26B -$31.1M $31.04 213
2022 Q1 41.7M $1.71B -$3.01M $41.06 228
2021 Q4 42.4M $1.85B -$78.9M $43.47 237
2021 Q3 44.3M $2.22B -$14.7M $50.07 268
2021 Q2 44M $2.77B -$90.9M $62.99 283
2021 Q1 44.5M $4.13B +$74.2M $92.91 334
2020 Q4 41M $3.68B +$69M $89.60 346
2020 Q3 39.7M $4.1B -$172M $103.33 350
2020 Q2 53.1M $4.16B -$1.23M $79.08 292
2020 Q1 43.6M $2.52B +$8M $57.86 251
2019 Q4 44.6M $2.41B -$6.24M $53.95 229
2019 Q3 44.1M $2.31B -$7.48M $52.28 235
2019 Q2 44.3M $2.14B +$145M $48.31 224
2019 Q1 44.2M $2.24B +$84.3M $50.52 264
2018 Q4 42.4M $2.51B +$49.8M $59.28 291
2018 Q3 41.5M $2.73B +$23.3M $65.83 265
2018 Q2 41.5M $2.1B +$58.2M $50.49 254
2018 Q1 40.9M $2.15B +$61M $52.65 268
2017 Q4 38.9M $1.81B +$151M $46.47 232
2017 Q3 36.9M $1.49B +$60.9M $40.45 193
2017 Q2 35.6M $1.2B +$5.03M $33.91 179
2017 Q1 34.6M $1B +$86.4M $29.04 172
2016 Q4 34.8M $1.14B -$15.8M $32.84 202
2016 Q3 35.9M $1.13B -$1.4M $31.53 197
2016 Q2 35.5M $998M +$87.1M $28.12 213
2016 Q1 32.8M $1.19B +$24.1M $36.35 204
2015 Q4 32.3M $1.29B +$25.4M $40.01 199
2015 Q3 32M $912M +$33.5M $28.49 189
2015 Q2 30.5M $1B +$19.8M $32.95 178
2015 Q1 30.3M $873M +$37.4M $28.76 167
2014 Q4 28.9M $786M -$144K $27.23 159
2014 Q3 28.8M $615M -$34.8K $21.31 158
2014 Q2 28.7M $644M +$10.8M $22.46 155
2014 Q1 28.6M $722M +$91M $25.27 161